Field evaluation of the gag-based heteroduplex mobility assay for genetic subtyping of circulating recombinant forms of human immunodeficiency virus type 1 in Abidjan, Côte d'Ivoire
- PMID: 12843043
- PMCID: PMC165334
- DOI: 10.1128/JCM.41.7.3056-3059.2003
Field evaluation of the gag-based heteroduplex mobility assay for genetic subtyping of circulating recombinant forms of human immunodeficiency virus type 1 in Abidjan, Côte d'Ivoire
Abstract
The gag-based heteroduplex mobility assay (gag-HMA) was evaluated for its ease and reliability in subtyping circulating recombinant forms (CRFs) of human immunodeficiency virus type 1 (HIV-1) in Côte d'Ivoire. One hundred thirty-two plasma samples were analyzed blindly for HIV-1 subtypes by sequencing the pol gene and by gag-HMA. DNA sequencing was used as the "gold standard." Of the 132 samples sequenced, 108 (82%) were CRF02_AG, 14 (11%) were pure subtype A, 5 (4%) were subtype G, 3 (2%) were subtype D, 1 was CRF01_AE, and 1 was subtype H. The gag-HMA correctly classified 126 (95.5%) of the samples. Of the 108 samples that were classified as CRF02_AG by DNA sequencing, 107 (99%) were correctly identified by gag-HMA, resulting in a positive predictive value of 96.4%. The gag-HMA seems to be a valuable tool for understanding the molecular epidemiology of HIV-1 CRF02_AG in Côte d'Ivoire and West Africa, which could be important for developing and evaluating AIDS vaccines, although DNA sequencing remains necessary for accurate molecular epidemiology.
Figures

Similar articles
-
Measurement of HIV-1 CRF02_AG-specific T cell responses indicates the dominance of a p24gag epitope in blood donors in Abidjan, Cote d'Ivoire.J Infect Dis. 2005 Oct 15;192(8):1417-21. doi: 10.1086/466525. Epub 2005 Sep 9. J Infect Dis. 2005. PMID: 16170760
-
HIV-1 subtyping using gag/env heteroduplex mobility assay and peptide enzyme-linked immunosorbent assay.Asian Pac J Allergy Immunol. 2005 Jun-Sep;23(2-3):143-52. Asian Pac J Allergy Immunol. 2005. PMID: 16252845
-
Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G.AIDS Res Hum Retroviruses. 1999 Jan 1;15(1):3-9. doi: 10.1089/088922299311655. AIDS Res Hum Retroviruses. 1999. PMID: 10024047
-
Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis.Lancet Infect Dis. 2019 Feb;19(2):143-155. doi: 10.1016/S1473-3099(18)30647-9. Epub 2018 Nov 30. Lancet Infect Dis. 2019. PMID: 30509777
-
Emergence in Western African countries of MDR-TB, focus on Côte d'Ivoire.Biomed Res Int. 2013;2013:426709. doi: 10.1155/2013/426709. Epub 2013 Sep 4. Biomed Res Int. 2013. PMID: 24093098 Free PMC article. Review.
Cited by
-
Inferring viral population structures using heteroduplex mobility and DNA sequence analyses.J Virol Methods. 2013 Dec;194(1-2):169-77. doi: 10.1016/j.jviromet.2013.08.012. Epub 2013 Aug 29. J Virol Methods. 2013. PMID: 23994080 Free PMC article.
References
-
- Adje, C., R. Cheingsong, H. T. Roels, C. Maurice, G. Djomand, W. Verbiest, K. Hertogs, B. Larder, B. Monga, M. Peeters, S. Eholie, E. Bissagnene, M. Coulibaly, R. Respess, S. Z. Wiktor, T. Chorba, and J. N. Nkengasong for the UNAIDS HIV Drug Access Initiative, Abidjan, Côte d'Ivoire. 2001. High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote d'Ivoire. J. Acquir. Immune Defic. Syndr. 26:501-506. - PubMed
-
- Agwale, S. M., K. E. Robbins, L. Odama, A. Saekhou, C. Zeh, A. Edubio, O. M. Njoku, N. Sani-Gwarzo, M. F. Gboun, F. Gao, M. Reitz, D. Hone, T. M. Folks, D. Pieniazek, C. Wambebe, and M. L. Kalish. 2001. Development of an env gp41-based heteroduplex mobility assay for rapid human immunodeficiency virus type 1 subtyping. J. Clin. Microbiol. 39:2110-2114. - PMC - PubMed
-
- AIDS. 2001. Approaches to the development of broadly protective HIV vaccines: challenges posed by the genetic, biological and antigenic variability of HIV-1. Report from a meeting of the WHO-UNAIDS Vaccine Advisory Committee, Geneva, 21-23 February 2000. AIDS 15:W1-W25. - PubMed
-
- Baldrich-Rubio, E., S. Anagonou, K. Stirrups, E. Lafia, D. Candotti, H. Lee, and J. P. Allain. 2001. A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa. J. Gen. Virol. 82:1095-1106. - PubMed
-
- Barlow, K. L., I. D. Tatt, P. A. Cane, D. Pillay, and J. P. Clewley. 2001. Recombinant strains of HIV type 1 in the United Kingdom. AIDS Res. Hum. Retrovir. 17:467-474. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical